Targeting of high peak respiratory exchange ratio is safe and enhances the prognostic power of peak oxygen uptake for heart failure patients

Circulation Journal

Volumn 78, Issue 9, 2014, Pages 2268-2275

  Nakanishi, Michio ^a   Kumasaka, Reon ^a   Arakawa, Tetsuo ^a   Noguchi, Teruo ^a   Goto, Yoichi ^a   Takaki, Hiroshi ^a   Sugimachi, Masaru ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Exercise; Heart failure; Oxygen uptake; Prognosis; Respiratory exchange ratio

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN; OXYGEN;

ADULT; AGED; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; LEFT ATRIAL DIAMETER; LEFT VENTRICULAR END DIASTOLIC DIAMETER; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; POST EXERCISE HYPOTENSION; PREDICTION; PROGNOSIS; RADIOIMMUNOASSAY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SAFETY; SODIUM BLOOD LEVEL; ST SEGMENT DEPRESSION; BLOOD; BREATHING; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EXERCISE TEST; HEART STROKE VOLUME; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; RISK FACTOR; SURVIVAL RATE;

AGED; DISEASE-FREE SURVIVAL; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OXYGEN; OXYGEN CONSUMPTION; RESPIRATION; RISK FACTORS; STROKE VOLUME; SURVIVAL RATE;

EID: 84906816912     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0047     Document Type: Article

References (32)

1. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, et al; SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study. Lancet 2010; 376: 875-885.
2. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, et al; EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011; 364: 11-21.
3. Working Group on Cardiac Rehabilitation and Exercise Physiology and Working Group on Heart Failure of the European Society of Cardiology. Recommendations for exercise testing in chronic heart failure patients. Eur Heart J 2001; 22: 37-45.
4. Albouaini K, Egred M, Alahmar A, Wright DJ. Cardiopulmonary exercise testing and its application. Heart 2007; 93: 1285-1292.
5. Kato J, Koike A, Hoshimoto-Iwamoto M, Nagayama O, Sakurada K, Sato A, et al. Relation between oscillatory breathing and cardiopulmonary function during exercise in cardiac patients. Circ J 2013; 77: 661-666.
6. Takaya Y, Kumasaka R, Arakawa T, Ohara T, Nakanishi M, Noguchi T, et al. Impact of cardiac rehabilitation on renal function in patients with and without chronic kidney disease after acute myocardial infarction. Circ J 2014; 78: 377-384.
7. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778-786.
8. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in CHF. J Am Coll Cardiol 1997; 29: 1585-1590.
9. 2. Eur Heart J 2000; 21: 154-161.
10. Milani RV, Lavie CJ, Mehra MR, Ventura HO. Understanding the basics of cardiopulmonary exercise testing. Mayo Clin Proc 2006; 81: 1603-1611.
11. Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, et al. Clinician’s guide to cardiopulmonary exercise testing in adults: A scientific statement from the American Heart Association. Circulation 2010; 122: 191-225.
12. Chase PJ, Kenjale A, Cahalin LP, Arena R, Davis PG, Myers J, et al. Effects of respiratory exchange ratio on the prognostic value of peak oxygen consumption and ventilatory efficiency in patients with systolic heart failure. JACC Heart Fail 2013; 1: 427-432.
13. 2 prognostic reliability in patients with chronic heart failure and severely reduced exercise capacity. Am Heart J 2003; 145: 1102-1107.
14. Davies LC, Francis DP, Piepoli M, Scott AC, Ponikowski P, Coats AJ. Chronic heart failure in the elderly: Value of cardiopulmonary exercise testing in risk stratification. Heart 2000; 83: 147-151.
15. Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, Chase P, et al. Development of a ventilatory classification system in patients with heart failure. Circulation 2007; 115: 2410-2417.
16. Chase P, Arena R, Myers J, Abella J, Peberdy MA, Guazzi M, et al. Relation of the prognostic value of ventilatory efficiency to body mass index in patients with heart failure. Am J Cardiol 2008; 101: 348-352.
17. Myers J, Arena R, Dewey F, Bensimhon D, Abella J, Hsu L, et al. A cardiopulmonary exercise testing score for predicting outcomes in patients with heart failure. Am Heart J 2008; 156: 1177-1183.
18. Guazzi M, Myers J, Peberdy MA, Bensimhon D, Chase P, Arena R. Exercise oscillatory breathing in diastolic heart failure: Prevalence and prognostic insights. Eur Heart J 2008; 29: 2751-2759.
19. O’Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al; HF-ACTION Investigators. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009; 301: 1439-1450.
20. Arena R, Guazzi M, Myers J, Chase P, Bensimhon D, Cahalin LP, et al. The prognostic utility of cardiopulmonary exercise testing stands the test of time in patients with heart failure. J Cardiopulm Rehabil Prev 2012; 32: 198-202.
21. Corrà U, Giordano A, Bosimini E, Mezzani A, Piepoli M, Coats AJ, et al. Oscillatory ventilation during exercise in patients with chronic heart failure: Clinical correlates and prognostic implications. Chest 2002; 121: 1572-1580.
22. Tsutamoto T, Wada A, Maeda K. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction: Comparison with plasma angiotensin II and endothelin-1. Eur Heart J 1999; 20: 1799-1807.
23. Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, et al; Val-HeFT Investigators. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003; 107: 1278-1283.
24. Isnard R, Pousset F, Chafirovskaïa O, Carayon A, Hulot JS, Thomas D, et al. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure. Am Heart J 2003; 146: 729-735.
25. de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol 2004; 43: 1584-1589.
26. Krüger S, Graf J, Merx MW, Stickel T, Kunz D, Koch KC, et al. The value of cardiopulmonary exercise testing and brain natriuretic peptide plasma levels in predicting the prognosis of patients with chronic heart failure. Eur J Intern Med 2006; 17: 96-101.
27. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002; 90: 1284-1289.
28. Rossi A, Cicoira M, Zanolla L, Sandrini R, Golia G, Zardini P, et al. Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 1425-1430.
29. Gibbons LW, Mitchell TL, Gonzalez V. The safety of exercise testing. Prim Care 1994; 21: 611-629.
30. Keteyian SJ, Isaac D, Thadani U, Roy BA, Bensimhon DR, McKelvie R, et al; HF-ACTION Investigators. Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J 2009; 158: S72-S77.
31. Guazzi M, Myers J, Peberdy MA, Bensimhon D, Chase P, Pinkstaff S, et al. Echocardiography with tissue Doppler imaging and cardiopulmonary exercise testing in patients with heart failure: A correlative and prognostic analysis. Int J Cardiol 2010; 143: 323-329.
32. Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, Quinones MA, et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 2005; 45: 1223-1226.